Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction

Efficacy and Safety of Fluvastatin 80 mg or Valsartan 160 mg and Their Combination in Dyslipidemic Patients With Arterial Hypertension and Endothelial Dysfunction

Patients with mild to moderate hypertension, dyslipidemia (imbalanced blood lipids) and decreased vascular dilatation, receiving a cholesterol lowering diet were given either valsartan or fluvastatin for 8 weeks. At week 8 all patients were administered a combination treatment with valsartan 160 mg and fluvastatin 80 mg.

Inclusion Criteria:

• Arterial hypertension
• Dyslipidemia
• Cholesterol lowering diet

Exclusion Criteria:

• Constant antihypertensive treatment
• Diabetes mellitus
• Myocardial infarction or stroke in the previous 3 months

Other inclusion and exclusion criteria may apply